Epigenomics AG Share Price Deutsche Boerse AG
Stocks
ECX
DE000A11QW50
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.785 EUR | -1.92% |
|
+9.51% | -4.03% |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 22/07/25 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 824K 948K 767K 704K 1.33M 90.53M 1.35M 9.04M 3.55M 45.07M 3.56M 3.48M 151M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.79M 13.56M 10.98M 10.08M 19.03M 1.29B 19.32M 129M 50.77M 645M 50.94M 49.82M 2.16B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 28/02/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 31/05/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 04/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.92% | +9.51% | - | - | 953K | |
| -22.52% | -18.18% | +97.02% | +68.74% | 3.69B | |
| -6.66% | +1.35% | +120.41% | +167.42% | 3.59B | |
| -13.22% | -18.44% | +58.37% | -43.94% | 1.82B | |
| +3.44% | +4.55% | -28.26% | -36.48% | 2.17B | |
| +14.72% | +17.69% | +255.80% | +300.64% | 2.26B | |
| -2.67% | -2.81% | +180.77% | -41.91% | 969M | |
| +6.96% | -1.82% | -9.43% | +15.45% | 853M | |
| +1.29% | +6.41% | -37.76% | -14.48% | 511M | |
| +7.90% | -3.22% | -2.47% | - | 449M | |
| Average | -1.27% | -2.86% | +70.50% | +51.93% | 1.81B | |
| Weighted average by Cap. | -5.07% | -3.69% | +95.63% | +84.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.61K 22.34K 20.51K 38.73K 2.64M 39.33K 263K 103K 1.31M 104K 101K 4.4M |
| Net income | -3.35M -3.86M -3.12M -2.86M -5.41M -368M -5.49M -36.78M -14.43M -183M -14.48M -14.16M -614M | -314K -361K -292K -268K -507K -34.48M -515K -3.45M -1.35M -17.17M -1.36M -1.33M -57.56M |
| Net Debt | 10.46M 12.03M 9.73M 8.93M 16.87M 1.15B 17.13M 115M 45.02M 572M 45.17M 44.18M 1.92B | 10.97M 12.62M 10.21M 9.37M 17.7M 1.2B 17.97M 120M 47.22M 600M 47.38M 46.34M 2.01B |
Employees
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
- ECX Stock
Select your edition
All financial news and data tailored to specific country editions
